人工智能在干预性肺病学中的作用
Anna Kornafeld1, Greg Little2, Laura Frye3
1Mayo Clinic, Rochester, MN.
人工智能 (AI) 通过改进肺结节检测,机器人支气管镜和COPD表型学来增强干预性肺病学 (IP). 人工智能集成承诺更精确的诊断,高效的程序,和更好的患者结果在IP.
科学领域:
- 干预性肺病学 干预性肺病学
- 医疗人工智能 医疗人工智能
- 诊断成像 诊断成像 诊断成像
背景情况:
- 人工智能 (AI) 越来越多地融入医疗领域.
- 干预性肺病学 (IP) 为肺部疾病提供先进的诊断和治疗程序.
- 人工智能增强知识产权能力的潜力是研究的一个重要领域.
研究的目的:
- 审查人工智能在干预性肺病学中的当前和新兴应用.
- 突出AI对诊断,程序精度和患者结果的影响.
- 讨论AI在知识产权方面的挑战和未来方向.
主要方法:
- 审查人工智能应用,包括机器学习 (ML) 和深度学习 (DL) 在IP.
- 分析AI在肺结节检测,风险分层和支气管镜导航中的作用.
- 在机器人辅助支气管镜检查AI,EBUS,COPD表型,和多发性溢液分析.
主要成果:
- 人工智能改善了肺结节检测,基于放射学的风险分层和支气管镜导航.
- 人工智能提高了机器人辅助支气管镜的准确性和EBUS引导的程序.
- 人工智能有助于COPD表型,对BLVR的患者选择,以及多发性溢出管理.
结论:
- 人工智能正在彻底改变干预性肺病学,提高诊断和程序效率.
- 人工智能集成提供个性化治疗计划和优化患者选择.
- 负责任的AI实施是推动精准医学和IP患者护理的关键.
更多相关视频
07:53Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
Published on: October 13, 2023
05:33Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
相关概念视频
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Inhaled Medications
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
